CXCL1 and ovarian carcinoma: Further, the fractalkine receptor (CX3CR1) expressed by ovarian cancer cells has also been demonstrated to mediate ovarian cancer cell adhesion to mesothelium by interacting with its ligand CXCL1 present on the surface of mesothelial cells’ surface [22].